MK-2214
Slow early Alzheimer's disease progression
- Age 50-85
- Early Alzheimer's Disease
- Infusion
Join the fight against Alzheimer's and memory disorders. Your participation matters.
Let us help you find the right trial! We'll guide you through the selection process and connect you with trials that best fit your profile and needs.
Explore our active studies seeking participants like you to advance Alzheimer's research.
Slow early Alzheimer's disease progression
Evaluating a new treatment for early Alzheimer's
Assess delaying of the progression to symptomatic stages
Evaluating a treatment for cognitive impairment in AD

Understand what happens at every step, from the first screening to the final follow-up visits.
See the full processAll trials are supervised by medical professionals and ethics committees.
Receive personalized attention from leading longevity specialists.
Contribute to research that could help millions in the future.